Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial — Ander Regueiro (2014) | RDL Network
Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial
Revista Española de Cardiología (English Edition) 68(5): 382-389
Article 2014 English
Authors
AR
Ander Regueiro
DF
Diego Fernández-Rodríguez
SB
Salvatore Brugaletta
Abstract
1 min read
Introduction and objectives
The use of second-generation drug-eluting stents compared with bare-metal stents in patients with ST-segment elevation myocardial infarction reduces the rate of major adverse cardiac events. We aimed to evaluate the impact of sex on the performance of everolimus-eluting stents vs bare-metal stents in ST-segment elevation myocardial infarction at 2-year follow-up.
Methods
This is a sub-study of the EXAMINATION trial that randomized 1498 patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention to everolimus-eluting or bare-metal stents. Primary end point was combined all-cause death, any recurrent myocardial infarction, and any revascularization. All end points were analyzed according to sex at 2-year follow-up.
Results
Of 1498 patients included in the trial, 254 (17.0%) were women. Women were older and had higher prevalence of hypertension and lower prevalence of smoking compared with men. In contrast with men, stent diameter was smaller in women. After multivariate analysis, the primary end point was similar between women and men (hazard ratio=0.95; 95% confidence interval, 0.66-1.37), and among women, between those treated with bare-metal vs everolimus-eluting stents (hazard ratio=2.48; 95% confidence interval, 0.95-6.46). Women showed a lower rate of repeat revascularization than men (hazard ratio=0.55; 95% confidence interval, 0.32-0.95) despite worse baseline characteristics. This difference was driven by better performance of the everolimus-eluting stent in women.
Conclusions
Despite poorer baseline clinical characteristics, women with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention showed outcomes similar to men. The use of everolimus-eluting stents may represent an added value in women as it showed a reduced rate of repeated revascularization compared to men.
Salvatore Brugaletta, Josep Gómez‐Lara, Luis Ortega‐Paz, Víctor Alfonso Jiménez Díaz, Marcelo Jiménez, Pilar Jiménez‐Quevedo, Roberto Diletti, Vicente Mainar, Gianluca Campo, Antonio Silvestro, Jaume Maristany, Xacobe Flores‐Ríos, Loreto Oyarzabal, Antonio De Miguel-Castro, Andrés Íñiguez, Antonio Serra, Luis Nombela‐Franco, Alfonso Ielasi, Maurizio Tespili, Mattie Lenzen, Nieves Gonzalo, Pascual Bordes, Matteo Tebaldi, Simone Biscaglia, Juan José Rodríguez-Arias, Soheil Al‐Shaibani, Víctor Arévalos, Rafael Romaguera, Joan Antoni Gómez‐Hospital, Patrick W. Serruys, Manel Sabaté
Manel Sabaté, Lorenz Räber, Dik Heg, Salvatore Brugaletta, Henning Kelbæk, Ángel Cequier, Miodrag Ostojić, Andrés Íñiguez, David Tüller, Antonio Serra, Andreas Baumbach, Clemens von Birgelen, Rosana Hernández‐Antolín, Marco Roffi, Vicente Mainar, Marco Valgimigli, Patrick W. Serruys, Peter Jüni, Stephan Windecker
Salvatore Brugaletta, Tommaso Gori, Adrian F. Low, Petr Toušek, Eduardo Pinar, Josep Gómez‐Lara, Giancarla Scalone, Eberhard Schulz, Mark Y. Chan, Viktor Kočka, José Hurtado, Juan Antoni Gomez-Hospital, Thomas Münzel, Chi‐Hang Lee, Ángel Cequier, Mariano Valdés, Petr Widimský, Patrick W. Serruys, Manel Sabaté
Discussion(0)
No comments yet. Be the first to comment.